BayImmuNet currently co-operates with 22 biotechnology and pharma companies to link science and economy in the field of immunotherapy.
The areas of collaboration are defined in a common "strategy document".
To generate synergistic and multiplier effects BayImmuNet is integrated in biotechnology networking as well in Bavaria as on international level.
Partners are networks and clusters focused on biotechnology or medical science.
